表紙
市場調查報告書
商品編碼
1024991

前列腺肥大症 (BPH) ·前列腺治療的全球市場 - 產業分析,市場規模,佔有率,成長率,趨勢,預測:2020年∼2027年

Global Benign Prostatic Hyperplasia (BPH) and Prostate Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2020 to 2027

出版日期: | 出版商: Value Market Research | 英文 126 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球前列腺肥大症 (BPH) ·前列腺治療市場在過去幾年中達到顯著增長,預計在2021年∼2027年的預測期間內將大幅成長。

本報告提供全球前列腺肥大症 (BPH) ·前列腺治療市場相關調查分析,提供推動市場要素·阻礙因素·課題·機會,加上收益相關市場發展相關的系統性資訊。

目錄

第1章 序文

第2章 摘要整理

第3章 前列腺肥大症 (BPH) ·前列腺治療:產業分析

  • 簡介:市場動態
  • 推動市場要素
  • 阻礙市場要素
  • 機會
  • 產業趨勢
  • 波特的五力分析
  • 市場魅力分析

第4章 價值鏈分析

  • 價值鏈分析
  • 原料分析
  • 潛在的買主清單
  • 行銷流通管道

第5章 COVID-19疫情爆發的影響分析

  • COVID-19疫情爆發的影響分析
  • COVID-19的影響分析:生產·進口·出口·各需求
  • 市場:COVID-19以前 vs. COVID-19以後
  • COVID-19疫情影響評估
  • COVID-19:微/宏要素分析

第6章 全球前列腺肥大症 (BPH) ·前列腺治療市場分析:不同治療

  • 概要:不同治療
  • 實際成果資料與預測資料
  • 分析:不同治療
  • 藥物治療
  • 外科治療

第7章 全球前列腺肥大症 (BPH) ·前列腺治療市場分析:各地區

  • 各地區的預測
  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第8章 前列腺肥大症 (BPH) ·前列腺治療企業的競爭情形

  • 前列腺肥大症 (BPH) ·前列腺治療市場競爭
  • 夥伴關係/合作/契約
  • M&A
  • 新產品銷售
  • 其他的發展

第9章 企業簡介

  • 企業佔有率分析
  • 市場集中度
  • Abbott Laboratories
  • Allergan plc
  • Astellas Pharma, Inc.
  • Eli Lilly and Company
  • GlaxoSmithKline plc
  • Boehringer Ingelheim Pharma GmbH &Co. KG
  • Merck &Co., Inc.
  • Pfizer, Inc.
  • Sanofi
  • Teva Pharmaceutical Industries Limited
目錄
Product Code: VMR11210343

Value Market Research's latest report on the Global Benign Prostatic Hyperplasia (BPH) and Prostate Treatment Market identified a significant growth in the industry over the last few years and anticipates it to grow considerably within the forecast period of 2021-2027.

The global benign prostatic hyperplasia (bph) and prostate treatment market report provides a complete evaluation of the market for the forecast period. The report consists of various segments as well as an analysis of the factors playing a significant role in the market. The factors include the drivers, restraints, challenges and opportunities and the impact of these factors on the market has been provided in the report. The drivers and restraints are classified as intrinsic factors while the opportunities and challenges are classified as extrinsic factors of the market. The global benign prostatic hyperplasia (bph) and prostate treatment market study provides an insight on the developments of the market in terms of revenue throughout the specified period.

This report provides a complete analysis for the global benign prostatic hyperplasia (bph) and prostate treatment market. An in-depth secondary research, primary interviews and in-house expert reviews are responsible for providing the market estimates for the global benign prostatic hyperplasia (bph) and prostate treatment market. These market estimates have been put together by studying the impact of different social, political and economic factors along with the current market dynamics that are affecting the global benign prostatic hyperplasia (bph) and prostate treatment market growth.

The report begins with the market overview, followed by a crisp executive summary. The Porter's Five Forces analysis covered in this study will assist in understanding the five forces namely buyers bargaining power, suppliers bargaining power, threat of new entrants, the threat of substitutes and the degree of competition in the global benign prostatic hyperplasia (bph) and prostate treatment market. It also helps to explain the various participants such as system integrators, intermediaries and end users within the market. The report by Value Market Research also focuses on the competitive landscape of the global benign prostatic hyperplasia (bph) and prostate treatment market.

The market analysis involves a section exclusively to list the major players of the global benign prostatic hyperplasia (bph) and prostate treatment market wherein our analysts provide an insight into the financial statements of all the key players along with its key development product. The company profile section in the report also provides a business overview and financial information. The companies provided in this section can be customized as per the client's requirement.

The Benign Prostatic Hyperplasia (BPH) and Prostate Treatment Market Report Segments the market as below-

By Therapy

Drug Treatment (Alpha Blockers, 5-Alpha Reductase Inhibitor, Phosphodiesterase-5 Inhibitors, Others)

Surgical Treatment (Transurethral Resection of the Prostate (TURP), Transurethral Microwave Thermotherapy (TUMT), Transurethral Needle Ablation of the Prostate (TUNA), Laser Therapy, Prostatic Stenting, UroLift Therapy, Rezum Therapy, Other)

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . BENIGN PROSTATIC HYPERPLASIA (BPH) AND PROSTATE TREATMENT - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 By Therapy
    • 3.7.2 By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

  • 5.1. Impact Analysis of Covid-19 Outbreak
    • 5.1.1. Direct Impact on Production
    • 5.1.2. Supply Chain and Market Disruption
    • 5.1.3. Financial Impact on Firms and Financial Markets
  • 5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
  • 5.3. Market: Pre V/S Post COVID-19
  • 5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
  • 5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL BENIGN PROSTATIC HYPERPLASIA (BPH) AND PROSTATE TREATMENT MARKET ANALYSIS BY THERAPY

  • 6.1 Overview by Therapy
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Therapy
  • 6.4 Drug Treatment Market by Regions
  • 6.5 Surgical Treatment Market by Regions

7 . GLOBAL BENIGN PROSTATIC HYPERPLASIA (BPH) AND PROSTATE TREATMENT MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America
    • 7.3.1. Overview, Historic and Forecast Data
    • 7.3.2. North America By Segment
    • 7.3.3. North America By Country
    • 7.3.4. United State
    • 7.3.5. Canada
    • 7.3.6. Mexico
  • 7.4. Europe
    • 7.4.1. Overview, Historic and Forecast Data
    • 7.4.2. Europe by Segment
    • 7.4.3. Europe by Country
    • 7.4.4. United Kingdom
    • 7.4.5. France
    • 7.4.6. Germany
    • 7.4.7. Italy
    • 7.4.8. Russia
    • 7.4.9. Rest Of Europe
  • 7.5. Asia Pacific
    • 7.5.1. Overview, Historic and Forecast Data
    • 7.5.2. Asia Pacific by Segment
    • 7.5.3. Asia Pacific by Country
    • 7.5.4. China
    • 7.5.5. India
    • 7.5.6. Japan
    • 7.5.7. South Korea
    • 7.5.8. Australia
    • 7.5.9. Rest Of Asia Pacific
  • 7.6. Latin America
    • 7.6.1. Overview, Historic and Forecast Data
    • 7.6.2. Latin America by Segment
    • 7.6.3. Latin America by Country
    • 7.6.4. Brazil
    • 7.6.5. Argentina
    • 7.6.6. Peru
    • 7.6.7. Chile
    • 7.6.8. Rest of Latin America
  • 7.7. Middle East & Africa
    • 7.7.1. Overview, Historic and Forecast Data
    • 7.7.2. Middle East & Africa by Segment
    • 7.7.3. Middle East & Africa by Country
    • 7.7.4. Saudi Arabia
    • 7.7.5. UAE
    • 7.7.6. Israel
    • 7.7.7. South Africa
    • 7.7.8. Rest Of Middle East And Africa

8 . COMPETITIVE LANDSCAPE OF THE BENIGN PROSTATIC HYPERPLASIA (BPH) AND PROSTATE TREATMENT COMPANIES

  • 8.1. Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9 . COMPANY PROFILES OF BENIGN PROSTATIC HYPERPLASIA (BPH) AND PROSTATE TREATMENT INDUSTRY

  • 9.1. Company Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Abbott Laboratories
    • 9.3.1. Company Overview
    • 9.3.2. Financials
    • 9.3.3. Products
    • 9.3.4. Recent Developments
  • 9.4. Allergan plc
    • 9.4.1. Company Overview
    • 9.4.2. Financials
    • 9.4.3. Products
    • 9.4.4. Recent Developments
  • 9.5. Astellas Pharma, Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Financials
    • 9.5.3. Products
    • 9.5.4. Recent Developments
  • 9.6. Eli Lilly and Company
    • 9.6.1. Company Overview
    • 9.6.2. Financials
    • 9.6.3. Products
    • 9.6.4. Recent Developments
  • 9.7. GlaxoSmithKline plc
    • 9.7.1. Company Overview
    • 9.7.2. Financials
    • 9.7.3. Products
    • 9.7.4. Recent Developments
  • 9.8. Boehringer Ingelheim Pharma GmbH & Co. KG
    • 9.8.1. Company Overview
    • 9.8.2. Financials
    • 9.8.3. Products
    • 9.8.4. Recent Developments
  • 9.9. Merck & Co., Inc.
    • 9.9.1. Company Overview
    • 9.9.2. Financials
    • 9.9.3. Products
    • 9.9.4. Recent Developments
  • 9.10. Pfizer, Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Financials
    • 9.10.3. Products
    • 9.10.4. Recent Developments
  • 9.11. Sanofi
    • 9.11.1. Company Overview
    • 9.11.2. Financials
    • 9.11.3. Products
    • 9.11.4. Recent Developments
  • 9.12. Teva Pharmaceutical Industries Limited
    • 9.12.1. Company Overview
    • 9.12.2. Financials
    • 9.12.3. Products
    • 9.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  • COVID-19: Micro and Macro Factor Analysis
  • Analysis by Therapy (USD MN)
  • Drug Treatment Market by Geography (USD MN)
  • Surgical Treatment Market by Geography (USD MN)
  • Global Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton

LIST OF FIGURES

  • Research Scope of Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Report
  • Market Research Process
  • Market Research Methodology
  • Global Benign Prostatic Hyperplasia (Bph) And Prostate Treatment Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Therapy
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Therapy (USD MN)
  • Drug Treatment Market by Geography (USD MN)
  • Surgical Treatment Market by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Company Market Share Analysis, 2020

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.